Cingulate Inc. (NASDAQ:CINGW) Short Interest Update

Cingulate Inc. (NASDAQ:CINGW) was the recipient of a significant increase in short interest during the month of July. As of July 15th, there was short interest totaling 1,149 shares, an increase of 283.0% from the June 30th total of 300 shares. Based on an average trading volume of 6,798 shares, the short-interest ratio is presently 0.2 days.

Cingulate Stock Performance

Shares of Cingulate stock traded down $0.00 during trading on Monday, reaching $0.02. 17 shares of the stock were exchanged, compared to its average volume of 34,847. Cingulate has a 1 year low of $0.02 and a 1 year high of $0.16. The stock’s fifty day moving average is $0.02 and its 200 day moving average is $0.04.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.